- Home
- / Terumo
Terumo
Revenue
¥703.3 B
FY, 2022
Market Capitalization
¥2.9 T
2023-01-23
Terumo Summary
Company summary
- Overview
- Terumo is a manufacturer of medical devices and supplies. It offers pharmaceuticals, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers.
- Type
- Public
- Status
- Active
- Founded
- 1921
- HQ
- Tokyo, JP | view all locations
- Website
- https://www.terumo.com
- Cybersecurity rating
- ESG rating
Key people
Toshiaki Takagi, Director and Senior Managing Executive Officer
Shoji Hatano, Director and Managing Executive Officer
Kyo Nishikawa, Director and Managing Executive Officer
LocationsView all
65 locations detected
Tokyo, Tokyo HQ
Japan
2-44-1 Hatagaya Shibuya-ku
Aliso Viejo, CA
United States
35 Enterprise
Ann Arbor, MI
United States
6200 Jackson Rd
Coral Gables, FL
United States
121 Alhambra Plaza STE 1120
Franklin Township, NJ
United States
265 Davidson Ave #320, Somerset
Lakewood, CO
United States
10810 Collins Ave
Terumo Financials
Summary financials
- Revenue (Q2, 2023)
- ¥206.0B
- Gross profit (Q2, 2023)
- ¥124.5B
- Net income (Q2, 2023)
- ¥17.9B
- Cash (Q2, 2023)
- ¥212.6B
- EBIT (Q2, 2023)
- ¥25.3B
- Enterprise value
- $2.9T
